RepliCel Announces its Incoming Board of Directors
Successful Annual General Meeting Confirms Director Slate for 2020 VANCOUVER, Dec. 23, 2019 /PRNewswire/ – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is…
Comments Off on RepliCel Announces its Incoming Board of Directors